(R)-3'-((2-((2-(3-chlorophenyl)-2-hydroxyethyl)amino)ethyl)amino)-(1,1'-biphenyl)-3-carboxylic acid,
3'-((2-((2-(3-chlorophenyl)-2-hydroxyethyl)amino)ethyl)amino)-(1,1'-biphenyl)-3-carboxylic acid,
GW 427353,
GW-427353,
GW427353,
solabegron,
solabegron hydrochloride,
Solabegron,
GW427353,
252920-94-8,
(R)-3'-((2-((2-(3-Chlorophenyl)-2-hydroxyethyl)amino)ethyl)amino)-[1,1'-biphenyl]-3-carboxylic acid,
451470-34-1,
UNII-55P6YH9O6N,
GW 427353,
GW-427353,
55P6YH9O6N,
C23H23ClN2O3,
(R)-3'-((2-((2-(3-chlorophenyl)-2-hydroxyethyl)amino)ethyl)amino)-(1,1'-biphenyl)-3-carboxylic acid,
Solabegron [INN],
solabegronum,
(R)-3'-[[2-[[2-(3-chlorophenyl)-2-hydroxyethyl]amino]ethyl]amino]-[1,1'-biphenyl]-3-carboxylic acid,
CHEMBL208427,
GTPL9512,
SCHEMBL2596555,
CTK1A6716,
DTXSID50179932,
CHEBI:141346,
LLDXOPKUNJTIRF-QFIPXVFZSA-N,
ZINC1547346,
6224AB,
ANW-62569,
BDBM50002595,
DB06190,
SB17019,
compound 38 [PMID: 16640337],
AJ-26883,
HY-19436,
AX8233434,
TC-151314,
CS-0015536,
(R)-3'-(2-(2-(3-Chlorophenyl)-2-hydroxyethylamino)ethylamino)biphenyl-3-carboxylic acid,
3-[3-[2-[[(2R)-2-(3-chlorophenyl)-2-hydroxyethyl]amino]ethylamino]phenyl]benzoic acid,
(1,1'-Biphenyl)-3-carboxylic acid, 3'-((2-(((2R)-2-(3-chlorophenyl)-2-hydroxyethyl)amino)ethyl)amino)-,
[1,1'-Biphenyl]-3-carboxylicacid, 3'-[[2-[[(2R)-2-(3-chlorophenyl)-2-hydroxyethyl]amino]ethyl]amino]-,
[1,1'-Biphenyl]-3-carboxylicacid,3'-[[2-[[(2R)-2-(3-chlorophenyl)-2-hydroxyethyl]aMino]ethyl]aMino]-,
3'-[(2-{[(2R)-2-(3-chlorophenyl)-2-hydroxyethyl]amino}ethyl)amino][biphenyl]-3-carboxylic acid,
Solabegron Hydrochloride,
UNII-GU14FR8D4A,
Solabegron hydrochloride [USAN],
ACN-S001762,
Solabegron Hydrochloride [USAN:INN],
CID9887812,
GW 427353B,
C523977,
3-[3-[2-[[2-(3-chlorophenyl)-2-hydroxy-ethyl]amino]ethylamino]phenyl]benzoic Acid,
3'-((2-((2-(3-Chlorophenyl)-2-hydroxyethyl)amino)ethyl)amino)-(1,1'-biphenyl)-3-carboxylic acid,